Axogen Inc vs Cytokinetics Inc — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Cytokinetics Inc trades at $76.61 (market cap $10.63B). The key difference: Cytokinetics Inc is far larger — about 4.1× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | CYTK | |
|---|---|---|
Market Cap | $2.61B | $10.63B |
Sector | Technology | Technology |
52-Week High | $48.48 | $87.26 |
52-Week Low | $14.16 | $34.31 |
Enterprise Value | $2.52B | $10.74B |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →